323 related articles for article (PubMed ID: 32579952)
1. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
Gómez-Pastora J; Weigand M; Kim J; Wu X; Strayer J; Palmer AF; Zborowski M; Yazer M; Chalmers JJ
Clin Chim Acta; 2020 Oct; 509():249-251. PubMed ID: 32579952
[No Abstract] [Full Text] [Related]
2. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Perricone C; Bartoloni E; Bursi R; Cafaro G; Guidelli GM; Shoenfeld Y; Gerli R
Immunol Res; 2020 Aug; 68(4):213-224. PubMed ID: 32681497
[TBL] [Abstract][Full Text] [Related]
3. Two consecutive myocardial tissue insults for inpatients with COVID-19.
Su M; Peng J; Wu M; Deng W; Yang Y; Peng YG
Crit Care; 2020 May; 24(1):259. PubMed ID: 32456648
[No Abstract] [Full Text] [Related]
4. The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort.
Ayanian S; Reyes J; Lynn L; Teufel K
Biomark Med; 2020 Aug; 14(12):1091-1097. PubMed ID: 32677844
[No Abstract] [Full Text] [Related]
5. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
Wanderer JP; Nathan N
Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2-related atypical thyroiditis.
Muller I; Cannavaro D; Dazzi D; Covelli D; Mantovani G; Muscatello A; Ferrante E; Orsi E; Resi V; Longari V; Cuzzocrea M; Bandera A; Lazzaroni E; Dolci A; Ceriotti F; Re TE; Gori A; Arosio M; Salvi M
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):739-741. PubMed ID: 32738929
[No Abstract] [Full Text] [Related]
7. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
Nahum J; Morichau-Beauchant T; Daviaud F; Echegut P; Fichet J; Maillet JM; Thierry S
JAMA Netw Open; 2020 May; 3(5):e2010478. PubMed ID: 32469410
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.
Ielapi N; Licastro N; Provenzano M; Andreucci M; Franciscis S; Serra R
Biomark Med; 2020 Jun; 14(9):713-716. PubMed ID: 32426991
[No Abstract] [Full Text] [Related]
9. Cautious interpretation of antiphospholipid antibodies in COVID-19.
Mehta S; Bhandari S; Mehta S
Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
[No Abstract] [Full Text] [Related]
10. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
[No Abstract] [Full Text] [Related]
11. Non-Specific Laboratory Tests in Patients with COVID-19.
Borai A
Ann Clin Lab Sci; 2020 Jul; 50(4):528-535. PubMed ID: 32826251
[TBL] [Abstract][Full Text] [Related]
12. Low glycosylated ferritin is a sensitive biomarker of severe COVID-19.
Fauter M; Viel S; Zaepfel S; Pradat P; Fiscus J; Villard M; Garnier L; Walzer T; Sève P; Henry T; Jamilloux Y
Cell Mol Immunol; 2020 Nov; 17(11):1183-1185. PubMed ID: 32917980
[No Abstract] [Full Text] [Related]
13. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
[TBL] [Abstract][Full Text] [Related]
14. Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients.
Chen D; Sun W; Li J; Wei B; Liu W; Wang X; Song F; Chen L; Yang J; Yu L
Mediators Inflamm; 2020; 2020():3764515. PubMed ID: 33061826
[TBL] [Abstract][Full Text] [Related]
15. The unique characteristics of COVID-19 coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
Li T; Wang L; Wang H; Gao Y; Hu X; Li X; Zhang S; Xu Y; Wei W
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2447-2455. PubMed ID: 32613308
[TBL] [Abstract][Full Text] [Related]
17. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.
Feld J; Tremblay D; Thibaud S; Kessler A; Naymagon L
Int J Lab Hematol; 2020 Dec; 42(6):773-779. PubMed ID: 32790918
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients.
Fourati S; Hue S; Pawlotsky JM; Mekontso-Dessap A; de Prost N
Intensive Care Med; 2020 Sep; 46(9):1781-1783. PubMed ID: 32572527
[No Abstract] [Full Text] [Related]
19. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
20. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19.
Solodky ML; Galvez C; Russias B; Detourbet P; N'Guyen-Bonin V; Herr AL; Zrounba P; Blay JY
Ann Oncol; 2020 Aug; 31(8):1087-1088. PubMed ID: 32360743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
